The Administrative Core (Core A) of the CFAR, under the direction of the three Emory CFAR Co-Directors: Drs. James Curran, Carlos del Rio, and Eric Hunter, is responsible for overall management of the Emory CFAR. The Administrative Core supports and promotes the CFAR mission by providing the institutional infrastructure and leadership from which all CFAR activities devolve. The mission of the Administrative Core is to lead, enable, and enhance HIV research by supporting a multi-disciplinary environment that promotes basic, clinical, behavioral, and translational HIV/AIDS research. The Administrative Core of the Emory CFAR accomplishes its goals through the following specific aims:
Aim 1 : Formulate a strategic plan for shaping, expanding, and optimizing NIH-funded AIDS research at Emory.
Aim 2 : Facilitate, fund, evaluate, and supervise all CFAR Core and Scientific Working Group activities.
Aim 3 : Promote interactions and communication between Emory CFAR members and with other US and international colleagues, partners, and collaborators.
Aim 4 : Monitor progress and assess the degree to which CFAR goals are being met;make mid-course adjustments and corrections as needed. These objectives will allow CFAR administrators, investigators, outside advisors, and collaborators to provide the fiscal, administrative, scientifi, and management oversight of Core facilities, services, communication, outreach, and educational activities that will enhance overall HIV research at Emory and its partners.
The Administrative Core (Core A) is responsible for the overall fiscal, administrative, scientific, and management oversight of the CFAR. The principal activities of Core A are the selection, funding, and evaluation of science and developmental cores, institutional leadership, recruitment, and development of new investigators, community outreach and the establishment of HIV research collaborations.
|Mustanski, Brian; Parsons, Jeffrey T; Sullivan, Patrick S et al. (2018) Biomedical and Behavioral Outcomes of Keep It Up!: An eHealth HIV Prevention Program RCT. Am J Prev Med 55:151-158|
|Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912|
|Sam, Soya S; Caliendo, Angela M; Ingersoll, Jessica et al. (2018) Evaluation of Performance Characteristics of Panther Fusion Assays for Detection of Respiratory Viruses from Nasopharyngeal and Lower Respiratory Tract Specimens. J Clin Microbiol 56:|
|Jenness, Samuel M; Goodreau, Steven M; Morris, Martina (2018) EpiModel: An R Package for Mathematical Modeling of Infectious Disease over Networks. J Stat Softw 84:|
|Singleton, Robyn; Winskell, Kate; McLeod, Haley et al. (2018) Young Africans' social representations of sexual abuse of power in their HIV-related creative narratives, 2005-2014: cultural scripts and applied possibilities. Cult Health Sex :1-16|
|Eckard, Allison Ross; Raggi, Paolo; O'Riordan, Mary Ann et al. (2018) Effects of vitamin D supplementation on carotid intima-media thickness in HIV-infected youth. Virulence 9:294-305|
|Lahiri, Cecile D; Brown, Nakita L; Ryan, Kevin J et al. (2018) HIV RNA persists in rectal tissue despite rapid plasma virologic suppression with dolutegravir-based therapy. AIDS 32:2151-2159|
|Hussen, Sophia A; Easley, Kirk A; Smith, Justin C et al. (2018) Social Capital, Depressive Symptoms, and HIV Viral Suppression Among Young Black, Gay, Bisexual and Other Men Who Have Sex with Men Living with HIV. AIDS Behav 22:3024-3032|
|Holloway, Ian W; Bednarczyk, Robert; Fenimore, Vincent L et al. (2018) Factors Associated with Immunization Opinion Leadership among Men Who Have Sex with Men in Los Angeles, California. Int J Environ Res Public Health 15:|
|Halpin, Sean N; Carruth, Edwin Clayton; Rai, Ramona P et al. (2018) Complementary and Alternative Medicine Among Persons living with HIV in the Era of Combined Antiretroviral Treatment. AIDS Behav 22:848-852|
Showing the most recent 10 out of 1005 publications